ID   NEB2_RAT                Reviewed;         817 AA.
AC   O35274;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   02-OCT-2024, entry version 186.
DE   RecName: Full=Neurabin-2 {ECO:0000305};
DE   AltName: Full=Neurabin-II;
DE   AltName: Full=Neural tissue-specific F-actin-binding protein II;
DE   AltName: Full=PP1bp134;
DE   AltName: Full=Protein phosphatase 1 regulatory subunit 9B;
DE   AltName: Full=Spinophilin {ECO:0000303|PubMed:15743906};
DE   AltName: Full=p130;
GN   Name=Ppp1r9b {ECO:0000312|RGD:632281};
GN   Synonyms=Spino {ECO:0000303|PubMed:15743906};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9275233; DOI=10.1073/pnas.94.18.9956;
RA   Allen P.B., Ouimet C.C., Greengard P.;
RT   "Spinophilin, a novel protein phosphatase 1 binding protein localized to
RT   dendritic spines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:9956-9961(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PROTEIN SEQUENCE OF 4-24; 164-182;
RP   199-242; 449-480; 678-689 AND 776-791.
RC   TISSUE=Brain;
RX   PubMed=9452470; DOI=10.1074/jbc.273.6.3470;
RA   Satoh A., Nakanishi H., Obaishi H., Wada M., Takahashi K., Satoh K.,
RA   Hirao K., Nishioka H., Hata Y., Mizoguchi A., Takai Y.;
RT   "Neurabin-II/spinophilin. An actin filament-binding protein with one pdz
RT   domain localized at cadherin-based cell-cell adhesion sites.";
RL   J. Biol. Chem. 273:3470-3475(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 100-767, AND INTERACTION WITH D2DR.
RX   PubMed=10391935; DOI=10.1074/jbc.274.28.19894;
RA   Smith F.D., Oxford G.S., Milgram S.L.;
RT   "Association of the D2 dopamine receptor third cytoplasmic loop with
RT   spinophilin, a protein phosphatase-1-interacting protein.";
RL   J. Biol. Chem. 274:19894-19900(1999).
RN   [4]
RP   CHARACTERIZATION.
RC   TISSUE=Brain;
RX   PubMed=10585469; DOI=10.1074/jbc.274.50.35845;
RA   MacMillan L.B., Bass M.A., Cheng N., Howard E.F., Tamura M., Strack S.,
RA   Wadzinski B.E., Colbran R.J.;
RT   "Brain actin-associated protein phosphatase 1 holoenzymes containing
RT   spinophilin, neurabin, and selected catalytic subunit isoforms.";
RL   J. Biol. Chem. 274:35845-35854(1999).
RN   [5]
RP   INTERACTION WITH TGN38.
RX   PubMed=10514494; DOI=10.1074/jbc.274.42.30080;
RA   Stephens D.J., Banting G.;
RT   "Direct interaction of the trans-Golgi network membrane protein, TGN38,
RT   with the F-actin binding protein, neurabin.";
RL   J. Biol. Chem. 274:30080-30086(1999).
RN   [6]
RP   CHARACTERIZATION, INTERACTION WITH PP1, AND MUTAGENESIS.
RX   PubMed=10194355; DOI=10.1021/bi982900m;
RA   Hsieh-Wilson L.C., Allen P.B., Watanabe T., Nairn A.C., Greengard P.;
RT   "Characterization of the neuronal targeting protein spinophilin and its
RT   interactions with protein phosphatase-1.";
RL   Biochemistry 38:4365-4373(1999).
RN   [7]
RP   INTERACTION WITH ADRA2A; ADRA2B AND ADRA2C.
RX   PubMed=11154706; DOI=10.1074/jbc.m011679200;
RA   Richman J.G., Brady A.E., Wang Q., Hensel J.L., Colbran R.J., Limbird L.E.;
RT   "Agonist-regulated Interaction between alpha2-adrenergic receptors and
RT   spinophilin.";
RL   J. Biol. Chem. 276:15003-15008(2001).
RN   [8]
RP   SUBCELLULAR LOCATION, INTERACTION WITH ACTIN AND PPP1CA, PHOSPHORYLATION AT
RP   SER-94; SER-100 AND SER-177, AND MUTAGENESIS OF SER-17; SER-59; SER-87;
RP   SER-94; SER-99; SER-100; SER-122; SER-126 AND SER-177.
RX   PubMed=12417592; DOI=10.1074/jbc.m205754200;
RA   Hsieh-Wilson L.C., Benfenati F., Snyder G.L., Allen P.B., Nairn A.C.,
RA   Greengard P.;
RT   "Phosphorylation of spinophilin modulates its interaction with actin
RT   filaments.";
RL   J. Biol. Chem. 278:1186-1194(2003).
RN   [9]
RP   INTERACTION WITH TIAM1 AND RASGRF1.
RX   PubMed=12531897; DOI=10.1074/jbc.m207876200;
RA   Buchsbaum R.J., Connolly B.A., Feig L.A.;
RT   "Regulation of p70 S6 kinase by complex formation between the Rac guanine
RT   nucleotide exchange factor (Rac-GEF) Tiam1 and the scaffold spinophilin.";
RL   J. Biol. Chem. 278:18833-18841(2003).
RN   [10]
RP   INTERACTION WITH ACTIN.
RX   PubMed=15135218; DOI=10.1016/j.molbrainres.2003.12.020;
RA   Barnes A.P., Smith F.D. III, VanDongen H.M., VanDongen A.M., Milgram S.L.;
RT   "The identification of a second actin-binding region in
RT   spinophilin/neurabin II.";
RL   Brain Res. Mol. Brain Res. 124:105-113(2004).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15514983; DOI=10.1002/cne.20313;
RA   Ouimet C.C., Katona I., Allen P., Freund T.F., Greengard P.;
RT   "Cellular and subcellular distribution of spinophilin, a PP1 regulatory
RT   protein that bundles F-actin in dendritic spines.";
RL   J. Comp. Neurol. 479:374-388(2004).
RN   [12]
RP   PHOSPHORYLATION BY CAMK2, PHOSPHORYLATION AT SER-100 AND SER-116, AND
RP   MUTAGENESIS OF SER-100 AND SER-116.
RX   PubMed=15228588; DOI=10.1111/j.1471-4159.2004.02491.x;
RA   Grossman S.D., Futter M., Snyder G.L., Allen P.B., Nairn A.C.,
RA   Greengard P., Hsieh-Wilson L.C.;
RT   "Spinophilin is phosphorylated by Ca2+/calmodulin-dependent protein kinase
RT   II resulting in regulation of its binding to F-actin.";
RL   J. Neurochem. 90:317-324(2004).
RN   [13]
RP   FUNCTION IN DENDRITIC SPINE MORPHOGENESIS, SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH PPP1R2.
RX   PubMed=15743906; DOI=10.1091/mbc.e04-12-1054;
RA   Terry-Lorenzo R.T., Roadcap D.W., Otsuka T., Blanpied T.A., Zamorano P.L.,
RA   Garner C.C., Shenolikar S., Ehlers M.D.;
RT   "Neurabin/protein phosphatase-1 complex regulates dendritic spine
RT   morphogenesis and maturation.";
RL   Mol. Biol. Cell 16:2349-2362(2005).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH RGS1; RGS2; RGS4; RGS19; ADRA1B.
RX   PubMed=15793568; DOI=10.1038/ncb1237;
RA   Wang X., Zeng W., Soyombo A.A., Tang W., Ross E.M., Barnes A.P.,
RA   Milgram S.L., Penninger J.M., Allen P.B., Greengard P., Muallem S.;
RT   "Spinophilin regulates Ca2+ signalling by binding the N-terminal domain of
RT   RGS2 and the third intracellular loop of G-protein-coupled receptors.";
RL   Nat. Cell Biol. 7:405-411(2005).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100 AND SER-205, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 417-583 IN COMPLEX WITH HUMAN
RP   PP1CA.
RX   PubMed=20305656; DOI=10.1038/nsmb.1786;
RA   Ragusa M.J., Dancheck B., Critton D.A., Nairn A.C., Page R., Peti W.;
RT   "Spinophilin directs protein phosphatase 1 specificity by blocking
RT   substrate binding sites.";
RL   Nat. Struct. Mol. Biol. 17:459-464(2010).
CC   -!- FUNCTION: Seems to act as a scaffold protein in multiple signaling
CC       pathways. Modulates excitatory synaptic transmission and dendritic
CC       spine morphology. Binds to actin filaments (F-actin) and shows cross-
CC       linking activity. Binds along the sides of the F-actin. May play an
CC       important role in linking the actin cytoskeleton to the plasma membrane
CC       at the synaptic junction. Believed to target protein phosphatase 1/PP1
CC       to dendritic spines, which are rich in F-actin, and regulates its
CC       specificity toward ion channels and other substrates, such as AMPA-type
CC       and NMDA-type glutamate receptors. Plays a role in regulation of G-
CC       protein coupled receptor signaling, including dopamine D2 receptors and
CC       alpha-adrenergic receptors. May establish a signaling complex for
CC       dopaminergic neurotransmission through D2 receptors by linking
CC       receptors downstream signaling molecules and the actin cytoskeleton.
CC       Binds to ADRA1B and RGS2 and mediates regulation of ADRA1B signaling.
CC       May confer to Rac signaling specificity by binding to both, RacGEFs and
CC       Rac effector proteins. Probably regulates p70 S6 kinase activity by
CC       forming a complex with TIAM1. Required for hepatocyte growth factor
CC       (HGF)-induced cell migration (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:15743906, ECO:0000269|PubMed:15793568}.
CC   -!- SUBUNIT: Interacts with DCLK2 (By similarity). Possibly exists as a
CC       homodimer, homotrimer or a homotetramer. Interacts with F-actin,
CC       PPP1CA, neurabin-1, TGN38 and D(2) dopamine receptor. Interacts with
CC       RGS1, RGS2, RGS4, RGS19 and ADRA1B, ADRA2A, ADRA2B, ADRA2C, CDKN2A,
CC       PPP1R2, RASGFR1 and TIAM1. Interacts (via C-terminus) with SPATA13 (via
CC       C-terminal tail) (By similarity). Interacts with ADRA2B (By
CC       similarity). {ECO:0000250|UniProtKB:Q6R891,
CC       ECO:0000250|UniProtKB:Q96SB3}.
CC   -!- INTERACTION:
CC       O35274; P61169: Drd2; NbExp=2; IntAct=EBI-80022, EBI-80012;
CC       O35274; P63088: Ppp1cc; NbExp=3; IntAct=EBI-80022, EBI-80049;
CC       O35274; P62136: PPP1CA; Xeno; NbExp=8; IntAct=EBI-80022, EBI-357253;
CC       O35274; P29350: PTPN6; Xeno; NbExp=2; IntAct=EBI-80022, EBI-78260;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Nucleus {ECO:0000250}.
CC       Postsynaptic density {ECO:0000269|PubMed:15514983}. Cell junction,
CC       adherens junction. Cell projection, dendritic spine
CC       {ECO:0000269|PubMed:15514983}. Cytoplasm {ECO:0000250}. Cell membrane
CC       {ECO:0000250}. Cell projection, lamellipodium {ECO:0000250}. Cell
CC       projection, filopodium {ECO:0000250}. Cell projection, ruffle membrane
CC       {ECO:0000250}. Note=Enriched at synapse and cadherin-based cell-cell
CC       adhesion sites. In neurons, both cytosolic and membrane-associated, and
CC       highly enriched in the postsynaptic density apposed to exitatory
CC       synapses (PubMed:15514983). Colocalizes with PPP1R2 at actin-rich
CC       adherens junctions in epithelial cells and in dendritic spines.
CC       Accumulates in the lamellipodium, filopodium and ruffle membrane in
CC       response to hepatocyte growth factor (HGF) treatment (By similarity).
CC       {ECO:0000250, ECO:0000269|PubMed:15514983}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Abundantly expressed in the brain.
CC       Expressed at highest levels in hippocampus and at lower levels in the
CC       cortex, cerebellum and brainstem. Localizes to the dendritic spines of
CC       neurons. Also localizes to aspiny neurons, such as GABAergic
CC       interneurons.
CC   -!- DEVELOPMENTAL STAGE: Expression is low during embryogenesis and
CC       increases around postnatal day 21.
CC   -!- DOMAIN: The PP1 binding region is natively unstructured, upon PP1
CC       binding, it acquires structure, blocks a substrate-binding site, and
CC       restricts PP1 phosphatase specificity to a subset of substrates.
CC   -!- PTM: Stimulation of D1 (but not D2) dopamine receptors induces Ser-94
CC       and Ser-177 phosphorylation. Dephosphorylation of these residues is
CC       mediated by PP1 and possibly PP2A. Spinophilin unphosphorylated or
CC       phosphorylated at Ser-94 is concentrated in the postsynaptic density,
CC       whereas spinophilin phosphorylated at Ser-177 is absent from the
CC       postsynaptic density and enriched in the cytosol. Phosphorylation of
CC       spinophilin disrupts its association with F-actin, but does not affect
CC       its binding to PP1. {ECO:0000269|PubMed:12417592,
CC       ECO:0000269|PubMed:15228588}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF016252; AAB72005.1; -; mRNA.
DR   EMBL; AF027181; AAC05183.1; -; Genomic_DNA.
DR   PIR; T03852; T03852.
DR   RefSeq; NP_445926.1; NM_053474.1.
DR   PDB; 2G5M; NMR; -; B=493-602.
DR   PDB; 3EGG; X-ray; 1.85 A; C/D=417-583.
DR   PDB; 3EGH; X-ray; 2.00 A; C/D=417-583.
DR   PDBsum; 2G5M; -.
DR   PDBsum; 3EGG; -.
DR   PDBsum; 3EGH; -.
DR   AlphaFoldDB; O35274; -.
DR   BMRB; O35274; -.
DR   SMR; O35274; -.
DR   BioGRID; 250040; 29.
DR   CORUM; O35274; -.
DR   DIP; DIP-30882N; -.
DR   IntAct; O35274; 8.
DR   MINT; O35274; -.
DR   STRING; 10116.ENSRNOP00000074026; -.
DR   iPTMnet; O35274; -.
DR   PhosphoSitePlus; O35274; -.
DR   jPOST; O35274; -.
DR   PaxDb; 10116-ENSRNOP00000005498; -.
DR   Ensembl; ENSRNOT00000089497.2; ENSRNOP00000074026.1; ENSRNOG00000052113.2.
DR   Ensembl; ENSRNOT00055056509; ENSRNOP00055046615; ENSRNOG00055032697.
DR   Ensembl; ENSRNOT00060037218; ENSRNOP00060030707; ENSRNOG00060021417.
DR   Ensembl; ENSRNOT00065029375; ENSRNOP00065023321; ENSRNOG00065017558.
DR   GeneID; 84686; -.
DR   KEGG; rno:84686; -.
DR   UCSC; RGD:632281; rat.
DR   AGR; RGD:632281; -.
DR   CTD; 84687; -.
DR   RGD; 632281; Ppp1r9b.
DR   eggNOG; KOG1945; Eukaryota.
DR   GeneTree; ENSGT00940000158833; -.
DR   HOGENOM; CLU_007401_1_0_1; -.
DR   InParanoid; O35274; -.
DR   OMA; APKVPHH; -.
DR   OrthoDB; 2911512at2759; -.
DR   PhylomeDB; O35274; -.
DR   EvolutionaryTrace; O35274; -.
DR   PRO; PR:O35274; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000052113; Expressed in frontal cortex and 19 other cell types or tissues.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:RGD.
DR   GO; GO:0005912; C:adherens junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0030864; C:cortical actin cytoskeleton; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:1990780; C:cytoplasmic side of dendritic spine plasma membrane; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IBA:GO_Central.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0044327; C:dendritic spine head; IDA:RGD.
DR   GO; GO:0032591; C:dendritic spine membrane; IDA:RGD.
DR   GO; GO:0044326; C:dendritic spine neck; IDA:RGD.
DR   GO; GO:0098890; C:extrinsic component of postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0030175; C:filopodium; ISS:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0030426; C:growth cone; IDA:RGD.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005654; C:nucleoplasm; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IDA:SynGO.
DR   GO; GO:0032587; C:ruffle membrane; ISS:UniProtKB.
DR   GO; GO:0097444; C:spine apparatus; IDA:SynGO.
DR   GO; GO:0003779; F:actin binding; IDA:RGD.
DR   GO; GO:0051015; F:actin filament binding; IDA:RGD.
DR   GO; GO:0031749; F:D2 dopamine receptor binding; IPI:RGD.
DR   GO; GO:0019900; F:kinase binding; IPI:RGD.
DR   GO; GO:0003676; F:nucleic acid binding; EXP:DisProt.
DR   GO; GO:0004672; F:protein kinase activity; IDA:RGD.
DR   GO; GO:0008157; F:protein phosphatase 1 binding; IDA:RGD.
DR   GO; GO:0004864; F:protein phosphatase inhibitor activity; IDA:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0044325; F:transmembrane transporter binding; IPI:RGD.
DR   GO; GO:0030042; P:actin filament depolymerization; IEP:RGD.
DR   GO; GO:0007015; P:actin filament organization; ISO:RGD.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; ISS:UniProtKB.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; IEP:RGD.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IEP:RGD.
DR   GO; GO:0071315; P:cellular response to morphine; ISS:UniProtKB.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEP:RGD.
DR   GO; GO:1901653; P:cellular response to peptide; IEP:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:RGD.
DR   GO; GO:0016358; P:dendrite development; ISO:RGD.
DR   GO; GO:0003006; P:developmental process involved in reproduction; IEP:RGD.
DR   GO; GO:0046847; P:filopodium assembly; ISS:UniProtKB.
DR   GO; GO:0021766; P:hippocampus development; IEP:RGD.
DR   GO; GO:0007612; P:learning; IEP:RGD.
DR   GO; GO:0060179; P:male mating behavior; IEP:RGD.
DR   GO; GO:0030308; P:negative regulation of cell growth; ISO:RGD.
DR   GO; GO:0031175; P:neuron projection development; IBA:GO_Central.
DR   GO; GO:1903829; P:positive regulation of protein localization; IDA:RGD.
DR   GO; GO:1904372; P:positive regulation of protein localization to actin cortical patch; IMP:RGD.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; IDA:RGD.
DR   GO; GO:1903119; P:protein localization to actin cytoskeleton; IMP:RGD.
DR   GO; GO:1990778; P:protein localization to cell periphery; IMP:RGD.
DR   GO; GO:2000474; P:regulation of opioid receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0150052; P:regulation of postsynapse assembly; ISO:RGD.
DR   GO; GO:0001932; P:regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:0061458; P:reproductive system development; IEP:RGD.
DR   GO; GO:0043200; P:response to amino acid; IEP:RGD.
DR   GO; GO:0001975; P:response to amphetamine; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0035902; P:response to immobilization stress; IEP:RGD.
DR   GO; GO:1904373; P:response to kainic acid; IEP:RGD.
DR   GO; GO:1904386; P:response to L-phenylalanine derivative; IEP:RGD.
DR   GO; GO:0035094; P:response to nicotine; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0034695; P:response to prostaglandin E; IEP:RGD.
DR   GO; GO:0048545; P:response to steroid hormone; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   CDD; cd00992; PDZ_signaling; 1.
DR   DisProt; DP00943; -.
DR   Gene3D; 2.30.42.10; -; 1.
DR   IDEAL; IID50058; -.
DR   InterPro; IPR040645; Neurabin-1/2_PDZ.
DR   InterPro; IPR043446; Neurabin-like.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   PANTHER; PTHR16154; NEURABIN; 1.
DR   PANTHER; PTHR16154:SF24; NEURABIN-2; 1.
DR   Pfam; PF00595; PDZ; 1.
DR   Pfam; PF17817; PDZ_5; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SUPFAM; SSF50156; PDZ domain-like; 1.
DR   PROSITE; PS50106; PDZ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Actin-binding; Cell junction; Cell membrane; Cell projection;
KW   Coiled coil; Cytoplasm; Cytoskeleton; Developmental protein;
KW   Differentiation; Direct protein sequencing; Membrane; Neurogenesis;
KW   Nucleus; Phosphoprotein; Reference proteome; Synapse.
FT   CHAIN           1..817
FT                   /note="Neurabin-2"
FT                   /id="PRO_0000071509"
FT   DOMAIN          496..584
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   REGION          1..154
FT                   /note="Actin-binding"
FT   REGION          1..93
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          100..371
FT                   /note="Interaction with D(2) dopamine receptor"
FT   REGION          117..166
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          164..282
FT                   /note="Actin-binding"
FT   REGION          169..255
FT                   /note="Interaction with ADRA2A, ADRA2B and ADRA2C"
FT                   /evidence="ECO:0000269|PubMed:11154706"
FT   REGION          216..445
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          417..494
FT                   /note="Interaction with protein phosphatase 1"
FT   REGION          480..525
FT                   /note="Interaction with RGS2"
FT                   /evidence="ECO:0000269|PubMed:15793568"
FT   REGION          595..816
FT                   /note="Interaction with TGN38"
FT                   /evidence="ECO:0000269|PubMed:10514494"
FT   COILED          595..616
FT                   /evidence="ECO:0000255"
FT   COILED          665..816
FT                   /evidence="ECO:0000255"
FT   MOTIF           447..451
FT                   /note="PP1-binding motif"
FT                   /evidence="ECO:0000269|PubMed:20305656"
FT   COMPBIAS        286..305
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        326..340
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        370..391
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        407..426
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         15
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6R891"
FT   MOD_RES         17
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6R891"
FT   MOD_RES         94
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:12417592"
FT   MOD_RES         100
FT                   /note="Phosphoserine; by CaMK2"
FT                   /evidence="ECO:0000269|PubMed:12417592,
FT                   ECO:0000269|PubMed:15228588, ECO:0007744|PubMed:22673903"
FT   MOD_RES         116
FT                   /note="Phosphoserine; by CaMK2"
FT                   /evidence="ECO:0000269|PubMed:15228588"
FT   MOD_RES         177
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:12417592"
FT   MOD_RES         192
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96SB3"
FT   MOD_RES         193
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96SB3"
FT   MOD_RES         205
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         207
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96SB3"
FT   MOD_RES         438
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96SB3"
FT   MOD_RES         658
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96SB3"
FT   MUTAGEN         17
FT                   /note="S->A: No effect on phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:12417592"
FT   MUTAGEN         59
FT                   /note="S->A: No effect on phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:12417592"
FT   MUTAGEN         87
FT                   /note="S->A: No effect on phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:12417592"
FT   MUTAGEN         94
FT                   /note="S->A: Diminishes phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:12417592"
FT   MUTAGEN         99
FT                   /note="S->A: No effect on phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:12417592"
FT   MUTAGEN         100
FT                   /note="S->A: Diminishes phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:12417592,
FT                   ECO:0000269|PubMed:15228588"
FT   MUTAGEN         116
FT                   /note="S->A: Diminishes phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15228588"
FT   MUTAGEN         122
FT                   /note="S->A: No effect on phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:12417592"
FT   MUTAGEN         126
FT                   /note="S->A: No effect on phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:12417592"
FT   MUTAGEN         177
FT                   /note="S->A: Diminishes phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:12417592"
FT   MUTAGEN         447..451
FT                   /note="Missing: Abolishes protein phosphatase 1 binding."
FT                   /evidence="ECO:0000269|PubMed:10194355"
FT   MUTAGEN         451
FT                   /note="F->A: Abolishes protein phosphatase 1 binding."
FT                   /evidence="ECO:0000269|PubMed:10194355"
FT   STRAND          431..434
FT                   /evidence="ECO:0007829|PDB:3EGG"
FT   STRAND          456..461
FT                   /evidence="ECO:0007829|PDB:3EGG"
FT   TURN            464..466
FT                   /evidence="ECO:0007829|PDB:3EGG"
FT   HELIX           476..489
FT                   /evidence="ECO:0007829|PDB:3EGG"
FT   STRAND          492..500
FT                   /evidence="ECO:0007829|PDB:3EGG"
FT   STRAND          505..513
FT                   /evidence="ECO:0007829|PDB:3EGG"
FT   STRAND          515..518
FT                   /evidence="ECO:0007829|PDB:3EGG"
FT   STRAND          521..531
FT                   /evidence="ECO:0007829|PDB:3EGG"
FT   HELIX           536..540
FT                   /evidence="ECO:0007829|PDB:3EGG"
FT   STRAND          548..552
FT                   /evidence="ECO:0007829|PDB:3EGG"
FT   HELIX           562..571
FT                   /evidence="ECO:0007829|PDB:3EGG"
FT   STRAND          574..582
FT                   /evidence="ECO:0007829|PDB:3EGG"
SQ   SEQUENCE   817 AA;  89646 MW;  D31D3E94EE2FFB6A CRC64;
     MMKTEPRGPG GPLRSASPHR SAYEAGIQAL KPPDAPGPDE APKAAHHKKY GSNVHRIKSM
     FLQMGTTTGP PGEAGGASGM AEAPRASDRG VRLSLPRASS LNENVDHSAL LKLGTSVSER
     VSRFDSKPAP SAQPAPPPHP PSRLQETRKL FERSVPAASG GDKEAVARRL LRQERASLQD
     RKLDVVVRFN GSTEALDKLD ADAVSPTVSQ LSAVFEKADS RTGLHRAPGP PRAAGAPQVN
     SKLVTKRSRV FQPPPPPPAP SGDAATEKDR GPGGQQPPQH RVAPARPPPK PREVRKIKPV
     EVEESGESEA ESAPGEVIQA EVTVHAALEN GSTTATTASP APEEPKAEAV PEEEASSSVA
     TLERGVDNGR APDMAPEEVD ESKKEDFSEA DLVDVSAYSG LGEDSGGSAL EEDDEEDEED
     GEPPYEPESG CVEIPGLSEE EDPAPSRKIH FSTAPIQVFS TYSNEDYDRR NEDVDPMAAS
     AEYELEKRVE RLELFPVELE KDSEGLGISI IGMGAGADMG LEKLGIFVKT VTEGGAAHRD
     GRIQVNDLLV EVDGTSLVGV TQSFAASVLR NTKGRVRFMI GRERPGEQSE VAQLIQQTLE
     QERWQREMME QRYAQYGEDD EETGEYATDE DEELSPTFPG GEMAIEVFEL AENEDALSPV
     EMEPEKLVHK FKELQIKHAV TEAEIQQLKR KLQSLEQEKG RWRVEKAQLE QSVEENKERM
     EKLEGYWGEA QSLCQAVDEH LRETQAQYQA LERKYSKAKR LIKDYQQKEI EFLKKETAQR
     RVLEESELAR KEEMDKLLDK ISELEGNLQT LRNSNST
//
